Cerenis hires John Paolini as CMO
This article was originally published in Scrip
Executive Summary
Dr John Paolini has joined Cerenis Therapeutics, a biopharmaceutical company developing novel high-density lipoprotein therapies to treat cardiovascular and metabolic diseases, as chief medical officer. Dr Paolini has over 15 years of clinical and research experience in cardiovascular disease, having led development programmes for various drugs at both Merck & Co and Bayer Healthcare Pharmaceuticals.